Healthcare DIVE August 5, 2024
Rebecca Pifer

The struggling drugstore chain has been chipping away at its stake in Cencora, formerly known as AmerisourceBergen, since last summer.

Dive Brief:

  • Walgreens has once again cut its stake in drug distributor Cencora as the struggling pharmacy chain looks to boost funding.
  • The Illinois-based retailer announced last week it was selling more shares in Cencora for roughly $1.1 billion in proceeds. The sales lower Walgreens’ stake in Cencora to approximately 10% from 12%.
  • Walgreens said it will use the money to pay down debt and to fund its operations as it continues to pivot to a health services strategy.

Dive Insight:

Walgreens has struggled amid inadequate reimbursement in its core pharmacy business and rising costs of operating stores....

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma, Pharma / Biotech
Key Trends in the Evolution of PBMs and Their Future Impact on Drug Pricing and Pharmacy Operations
Healthcare leaders urge Congress to recognize pharmacists as providers
Pharma Pulse 11/25/24: Deepening Patient Relationships, Menopause May Increase Risk of Asthma & more
Trump tariffs could drive up generic drug costs: 5 takeaways
Bridging the Gap: Pharmacists' Role in Advancing Pharmacogenomic Testing Standards

Share This Article